Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-risk Mucinous Pancreatic Cystic Lesions.

Gastroenterology(2019)

引用 44|浏览64
暂无评分
摘要
We validated the ability of an ELISA with the monoclonal antibody Das-1 to detect PCLs at risk for malignancy with high levels of sensitivity and specificity. This biomarker might be used in conjunction with clinical guidelines to identify patients at risk for cancer.
更多
查看译文
关键词
Intraductal Papillary Mucinous Neoplasm (IPMN),Mucinous Cystic Neoplasm (MCN),Pancreatic Cancer,mAb Das-1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要